Global, Regional, and National Time Trends in the Burden of Epilepsy, 1990-2019: an Age-period-cohort Analysis for the Global Burden of Disease 2019 Study

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Sep 5

PMID 39233683

Authors

Tao Shan

Yahui Zhu

Haozhi Fan

Zeye Liu

Jing Xie

Mao Li

Shenqi Jing

Affiliations

Soon will be listed here.

Abstract

Background: Epilepsy is a non-communicable chronic brain disease that affects all age groups. There are approximately 50 million epilepsy patients worldwide, which is one of the most common neurological disorder. This study reports the time trends in the burden of epilepsy from 1999 to 2019.

Methods: We evaluated the disease burden and its temporal trends of epilepsy using the prevalence and years lived with disability (YLDs), which was estimated based on the Global Burden of Disease (GBD) 2019 study. The age-period-cohort (APC) model was used to estimate the temporal trends of the epilepsy prevalence and YLDs rates, and to analyze the relative risks of age, periods and queues (age/period/queue effects).

Results: In the past 30 years, the global age-standardized prevalence rate and age-standardized rate has increased by 29.61% and 27.02%, respectively. Globally, the APC model estimated the net drift of prevalence and YLDs were 0.88% (95% CI: 0.83-0.93) and 0.80% (95% CI: 0.75-0.85) per year. Among 204 countries and territories, the YLDs in 146 and prevalence 164 showed an increasing trend. And the risk of YLDs and prevalence increases with age, with the lowest risk among 0-4 years old and the highest risk among 75-79 years old. Unfavorable increasing period and cohort risks of YLDs and prevalence were observed.

Conclusion: Over the past 30 years, the YLDs and prevalence of epilepsy have gradually increased globally and unfavorable increasing period and cohort risks were observed. Emphasizing epilepsy prevention, strengthening epilepsy health education, optimizing older adults epilepsy diagnosis and treatment plans, and actively promoting epilepsy diagnosis and treatment plans can effectively reduce new cases of epilepsy and related disabilities.

References

Ding D, Zhou D, Sander J, Wang W, Li S, Hong Z . Epilepsy in China: major progress in the past two decades. Lancet Neurol. 2021; 20(4):316-326. DOI: 10.1016/S1474-4422(21)00023-5. View

Ngugi A, Bottomley C, Kleinschmidt I, Sander J, Newton C . Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010; 51(5):883-90. PMC: 3410521. DOI: 10.1111/j.1528-1167.2009.02481.x. View

Chen C, Turner S, Sholle E, Brown S, Blau V, Brouwer J . Evaluation of a REDCap-based Workflow for Supporting Federal Guidance for Electronic Informed Consent. AMIA Jt Summits Transl Sci Proc. 2019; 2019:163-172. PMC: 6568140. View

Rosenberg P, Check D, Anderson W . A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014; 23(11):2296-302. PMC: 4221491. DOI: 10.1158/1055-9965.EPI-14-0300. View

Bell A . Age period cohort analysis: a review of what we should and shouldn't do. Ann Hum Biol. 2020; 47(2):208-217. DOI: 10.1080/03014460.2019.1707872. View

Ding D, Hong Z, Chen G, Dai X, Wu J, Wang W . Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project. Epilepsia. 2008; 49(3):535-9. DOI: 10.1111/j.1528-1167.2007.01529_2.x. View

. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017; 16(11):877-897. PMC: 5641502. DOI: 10.1016/S1474-4422(17)30299-5. View

Scott R, Lhatoo S, Sander J . The treatment of epilepsy in developing countries: where do we go from here?. Bull World Health Organ. 2001; 79(4):344-51. PMC: 2566404. View

Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou E, Newton C, Preux P . Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 2014; 13(10):1029-44. PMC: 5497080. DOI: 10.1016/S1474-4422(14)70114-0. View

10.

Newton C, Garcia H . Epilepsy in poor regions of the world. Lancet. 2012; 380(9848):1193-201. DOI: 10.1016/S0140-6736(12)61381-6. View

11.

Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, Laxminarayan R . Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model. Epilepsia. 2016; 57(3):464-74. PMC: 5019268. DOI: 10.1111/epi.13294. View

12.

Fisher R, Acevedo C, Arzimanoglou A, Bogacz A, Cross J, Elger C . ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55(4):475-82. DOI: 10.1111/epi.12550. View

13.

Neligan A, Hauser W, Sander J . The epidemiology of the epilepsies. Handb Clin Neurol. 2012; 107:113-33. DOI: 10.1016/B978-0-444-52898-8.00006-9. View

14.

Asadi-Pooya A, Brigo F, Lattanzi S, Blumcke I . Adult epilepsy. Lancet. 2023; 402(10399):412-424. DOI: 10.1016/S0140-6736(23)01048-6. View

15.

Ding C, Wu Y, Chen X, Chen Y, Wu Z, Lin Z . Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019. Front Public Health. 2022; 10:952161. PMC: 9745318. DOI: 10.3389/fpubh.2022.952161. View

16.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

17.

Rosenberg P, Anderson W . Age-period-cohort models in cancer surveillance research: ready for prime time?. Cancer Epidemiol Biomarkers Prev. 2011; 20(7):1263-8. PMC: 3132831. DOI: 10.1158/1055-9965.EPI-11-0421. View

18.

Beghi E, Giussani G, Sander J . The natural history and prognosis of epilepsy. Epileptic Disord. 2015; 17(3):243-53. DOI: 10.1684/epd.2015.0751. View

19.

. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(4):357-375. PMC: 6416168. DOI: 10.1016/S1474-4422(18)30454-X. View

20.

Thurman D, Beghi E, Begley C, Berg A, Buchhalter J, Ding D . Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011; 52 Suppl 7:2-26. DOI: 10.1111/j.1528-1167.2011.03121.x. View